Evidence map›Paper›PMID 24757137›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2014

Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis.

Ingrid Fert, Nicolas Cagnard, Simon Glatigny, Franck Letourneur, Sébastien Jacques, Judith A Smith, Robert A Colbert, Joel D Taurog, Gilles Chiocchia, Luiza M Araujo and 1 more

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Lessons on SpA pathogenesis from animal models.Seminars in immunopathology · 2021
    Review
  18. Review
  19. Article
  20. Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15.Neurology(R) neuroimmunology & neuroinflammation · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

Ingrid FertUniversité Paris-Descartes, Sorbonne Paris Cité, Laboratoire d'Excellence Inflamex, Institut Cochin, and INSERM U1016, CNRS (UMR 8104), Paris, France.
Nicolas Cagnard
Simon Glatigny
Franck Letourneur
Sébastien Jacques
Judith A Smith
Robert A Colbert
Joel D Taurog
Gilles Chiocchia
Luiza M Araujo
Maxime Breban
Institut Cochin · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRHôpital Necker-Enfants Malades · FRInserm · FRNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USThe University of Texas Southwestern Medical Center · USUniversité Paris Cité · FRUniversity of Wisconsin–Madison · US

Funding

Clinical Support Services for the NIAMS Intramural Research ProgramZIDAR041180 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$119.2M
Pathogenic Mechanisms in SpondyloarthritisZIAAR041184 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$47.6M
MECHANISM AND CONSEQUENCES OF HLA-B 27 MISFOLDINGR01AR046177 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI GRIFFIN, THOMAS A · 2000 to 2010
$3.0M
HLA-B27 Misfolding in Spondyloarthropathy PathogenesisR01AR048372 · NIAMS · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI COLBERT, ROBERT A. · 2001 to 2005
$1.8M
NIAMS NIH HHS R01 AR046177NIAMS NIH HHS R01 AR048372
6 · The paper itself

Abstract

objectiveIn HLA-B27-transgenic rats, the development of a disorder that mimics spondyloarthritis (SpA) is highly correlated with dendritic cell (DC) dysfunction. The present study was undertaken to analyze the underlying mechanisms of this via transcriptome analysis.

methodsTranscriptome analysis of ex vivo-purified splenic CD103+CD4+ DCs from B27-transgenic rats and control rats was performed. Transcriptional changes in selected genes were confirmed by quantitative reverse transcriptase-polymerase chain reaction. A meta-analysis of our rat data and published data on gene expression in macrophages from ankylosing spondylitis (AS) patients was further performed.

resultsInterferon (IFN) signaling was the most significantly affected pathway in DCs from B27-transgenic rats; the majority of genes connected to IFN were underexpressed in B27-transgenic rats as compared to controls. This pattern was already present at disease onset, persisted over time, and was conserved in 2 disease-prone B27-transgenic rat lines. In DCs from B27-transgenic rats, we further found an up-regulation of suppressor of cytokine signaling 3 (which may account for reverse IFN signaling) and a down-regulation of interleukin-27 (a cytokine that opposes Th17 differentiation and promotes Treg cells). The meta-analysis of data on conventional DCs from rats and data on monocyte-derived macrophages from humans revealed 7 IFN-regulated genes that were negatively regulated in both human and rat SpA (i.e., IRF1, STAT1, CXCL9, CXCL10, IFIT3, DDX60, and EPSTI1).

conclusionOur results suggest that expression of HLA-B27 leads to a defect in IFNγ signaling in antigen-presenting cells in both B27-transgenic rats and SpA patients, which may result in Th17 expansion and Treg cell alteration (as shown in B27-transgenic rats) and contribute to disease pathogenesis.

Indexed as

AnimalsAntigen-Presenting CellsGene Expression ProfilingHLA-B27 AntigenHumansInterferon-gammaMacrophagesRatsRats, TransgenicSpondylarthritisSpondylitis, AnkylosingT-Lymphocytes, RegulatoryHLA-B27 AntigenInterferon-gamma

Identifiers

PMID24757137
PMCPMC4226235
OpenAlexW2100946553

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.